Sites

Delivering benefits to patients and sites

We support all sites, from very experienced to research-naïve, reducing site burden to allow more time dedicated to patient care. Our site support can be customised to fit a particular protocol, or to fit individual site needs. From access to our global site network, to resourcing and engagement via Site Engagement Liaisons and Clinical Trial Liaisons, we can help sites operationlise their clinical research more efficiently, leading to faster timelines, better study data, and higher patient satisfaction.

Accellacare Site Network

Greater access to patients and multi-specialty physicians

Explore

Accellacare Site Resourcing

Qualified staffing support for clinical research sites

Explore

FIRECREST Site portal

Simplifies and streamlines study delivery for sites and study teams

Explore

Digital Health Technologies

Optimise protocol strategies with fit-for-purpose digital measures

Explore

Centralised support services

ICON offers sites dedicated support through centralised services, allowing us to absorb the risk and upfront costs of participating in a clinical trial. Our centralised support team provides the people and processes to facilitate rapid study start, including medical oversight, site feasibility, patient recruitment, contracting & budgeting, quality & compliance, and project management.

Contracting

Our dedicated contracts team is well versed in clinical trial contracting to provide the best possible protection. Our services are technology-based in order to best manage the contracting process and status updates.

Budgeting

We offer an experienced and unbiased team, building global site budgets using an established database for fair market value and a procedure-level understanding of each protocol. We’re able to work with rate cards to negotiate budgets and have a regulatory focus in the EU and US providing >800 regulatory reports annually to meet Sunshine and EFPIA standards, customised to sponsor specifications

ICON’s Investigator Payments group is high performing in administering Investigator payments with >90% of payments made within 30 days of invoice receipt. Services extend to building study budgets, transparency reporting of payments, and clinical study tax management.

In this section

Connect with us

Related information:

The importance of communication in patient-centred clinical trials

How can we navigate this complex linguistic landscape while preserving the integrity of the original message and keep participants well informed?

The importance of a robust clinical outcome assessment strategy in your clinical trial

At ICON, we understand the nuances involved in creating a COA strategy that not only meets regulatory standards but also resonates with patients and stakeholders alike.

Why using COAs and DHTs together is the future of clinical research

Though both COAs and DHTs are tools used to evaluate a treatment’s impact, they often exist in separate spheres. We argue that combining these two approaches in the same study can help researchers gather better data and improve the likelihood of regulatory approval.

Enhancing diversity in clinical trials

To fully assess the efficacy and safety of a therapeutic indication, clinical trials must evaluate populations that are representative of the treatment population, as different people may experience the same disease differently.

Support and structure for faster start-up, increased patient recruitment and consistent quality.

The future of RWD and RWE in healthcare decision-making: Applications of novel real-world data collection methods for healthcare decision-making

Read insights from Jennifer Eriksson, Divisional Principal, on the use of real-world evidence and real-world data to inform healthcare decision-making and provide patients with rapid access to innovative healthcare technology.

Validating COAs: Key steps for accurate and reliable clinical trial data

With the increasing adoption of COAs, the importance of standardization across training, collection, and implementation to ensure high quality and consistent data collection has become apparent in recent decades.

DCT Tracker: Charting the next chapter for decentralisation

More than four years after decentralisation became a necessity in the clinical trials space, the sector is still finding its way around decentralised clinical trials (DCTs). And like any other paradigm shift, the journey has taken several turns.

Human-enabled AI driving enhancements in clinical trial site selection

In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.

How human-enabled AI is creating a new map for navigating site selection

Discover how AI transforms site selection in clinical research by leveraging data and human expertise through an ecosystem approach to optimise site ranking, patient enrolment, and study timelines.

Embedded and agile – The next phase of the DCT evolution

This article highlights how DCTs are now considered a patient centric model for sponsors that want to enhance the patient and site experience and generate more robust data.

Site Training for Clinical Trial Success

Learn more about what you need to reduce risk, increase compliance and enhance quality with a comprehensive training solution.